vimarsana.com

Latest Breaking News On - News ratings for virpax pharmaceuticals daily - Page 2 : vimarsana.com

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 51,500 shares, a decrease of 44.1% from the December 31st total of 92,100 shares. Currently, 0.6% of the company’s stock are sold short. Based on an […]

Vanguard-group-inc
Citigroup-inc
Virpax-pharmaceuticals
Renaissance-technologies
Virpax-pharmaceuticals-price-performance
Virpax-pharmaceuticals-company-profile
News-ratings-for-virpax-pharmaceuticals-daily
Virpax-pharmaceuticals-inc
Nasdaq
Hedge-funds-weigh-in-on-virpax-pharmaceuticals
Get-free-report

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Update

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totalling 92,100 shares, an increase of 479.2% from the December 15th total of 15,900 shares. Based on an average trading volume of 270,600 shares, the days-to-cover ratio […]

Renaissance-technologies
Virpax-pharmaceuticals
Virpax-pharmaceuticals-trading-down
Virpax-pharmaceuticals-inc
Institutional-trading-of-virpax-pharmaceuticals
Nasdaq
Virpax-pharmaceuticals-company-profile
Vanguard-group-inc
Citigroup-inc
News-ratings-for-virpax-pharmaceuticals-daily
Get-free-report

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Sees Significant Increase in Short Interest

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totalling 47,900 shares, a growth of 197.5% from the September 15th total of 16,100 shares. Based on an average daily volume of 20,900 shares, […]

Virpax-pharmaceuticals-price-performance
Virpax-pharmaceuticals-inc
News-ratings-for-virpax-pharmaceuticals-daily
Renaissance-technologies
Vanguard-group-inc
Nasdaq
Citigroup-inc
Virpax-pharmaceuticals
Get-free-report
Virpax-pharmaceuticals-daily
Nasdaq-vrpx

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Down 20.1% in August

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) saw a large decline in short interest in August. As of August 15th, there was short interest totalling 33,400 shares, a decline of 20.1% from the July 31st total of 41,800 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average […]

Virpax-pharmaceuticals-inc
Virpax-pharmaceuticals
News-ratings-for-virpax-pharmaceuticals-daily
Nasdaq
Virpax-pharmaceuticals-stock-performance
Vanguard-group-inc
Citigroup-inc
Renaissance-technologies
Virpax-pharmaceuticals-company-profile
Get-free-report
Virpax-pharmaceuticals-daily

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Up 56.8% in June

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) Short Interest Up 56.8% in June
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hedge-funds-weigh-in-on-virpax-pharmaceuticals
Citigroup-inc
Virpax-pharmaceuticals-inc
Virpax-pharmaceuticals-stock-performance
Renaissance-technologies
Nasdaq
Vanguard-group-inc
News-ratings-for-virpax-pharmaceuticals-daily
Virpax-pharmaceuticals
Get-free-report
Virpax-pharmaceuticals-daily
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.